Wordt geladen...
Advances in the Treatment of Metastatic Melanoma: Adoptive T Cell Therapy
Metastatic melanoma is notoriously resistant to chemotherapy and radiotherapy regimens. The prospect for newly diagnosed metastatic melanoma patients is grim with a median survival of less than a year. Currently, the only therapies resulting in long term disease free intervals, high dose Interleukin...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3500663/ https://ncbi.nlm.nih.gov/pubmed/22484193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2012.01.006 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|